A New Heat Therapy Device for Home-based Leg Heating in Patients With Lower-extremity Peripheral Artery Disease
1 other identifier
interventional
6
1 country
1
Brief Summary
The goal of the proposed pilot study is to evaluate the feasibility of a new leg heat therapy system treatment for patients with lower extremity PAD. The new system is comprised of leg-length water circulating pads surrounded by a separate pneumatic compression outer garment that compresses the pads against the skin for efficient heat transfer. The new leg garment is easily closed with a zipper. The air chambers automatically adjust the amount of air inflation enabling use of the garment independent of patient leg size. Six patients with PAD will be asked to complete daily (90 min/day) home-based leg HT for 12 weeks using the newly developed system. The primary study outcome is the change from baseline in walking performance on the 6-minute walk test at the 12-week follow-up. Secondary outcomes include plantar flexion power, as assessed using isokinetic dynamometry, sit-to-stand muscle power and perceived quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started May 2023
Shorter than P25 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2022
CompletedFirst Posted
Study publicly available on registry
April 19, 2022
CompletedStudy Start
First participant enrolled
May 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 7, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2024
CompletedResults Posted
Study results publicly available
August 15, 2025
CompletedAugust 15, 2025
August 1, 2025
8 months
April 13, 2022
July 11, 2025
August 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Six-minute Walk Distance
Participants will receive standardized instructions and will be asked to walk the greatest distance possible by walking back and forth along a 100-ft corridor for 6 min.
Baseline to 12-week follow-up
Secondary Outcomes (4)
Change in Walking Impairment Questionnaire Score
Baseline to 12-week follow-up
Device Usability Using the System Usability Scale
Baseline to 12-week follow-up
Change in Triceps Surae Peak Torque
Baseline to 12-week follow-up
Change in the Five Times Sit to Stand Test
Baseline to 12-week follow-up
Study Arms (1)
Home-based leg heat therapy
EXPERIMENTALPatients will be provided with the Aquilo heat therapy device and will be instructed on how to operate the equipment. The device will be used in accordance to the manufacturers recommendations. Patients will be asked to apply the therapy daily in the home setting for 12 week (90 min/day, 7 days/week).
Interventions
The Aquilo system consists of a garment that contains an inner water-circulating pad that is compressed by air bladders. The volume of air inflating the air bladders is pressure-controlled so the garment automatically adjusts to the shape and size of all legs. The touch screen console contains pre-programmed settings for ease of use. After baseline characteristics are established, patients will be provided with the Aquilo device and will be instructed on how to operate the equipment and how to rapidly remove the system if the alarm sounds or if they have any unusual feeling. Patients in both groups will also receive a logbook to record their sessions. Patients will undergo daily home-based leg HT (90 min/day, 7 days/week) for 12 weeks. Water at 42ºC will be perfused through the water-circulating garment for 90 min, with the goal of increasing skin temperature in the calf to \~37ºC.
Eligibility Criteria
You may qualify if:
- Men and women 60 years or older
- Resting ankle-brachial index (ABI) of 0.9 or less in at least one leg.
- Individuals with a resting ABI between 0.91 and 1.00 at baseline will be eligible if their ABI drops by 20% or greater following a heel-rise test.
You may not qualify if:
- Critical limb ischemia (ischemic rest pain or ischemia-related, non-healing wounds or tissue loss)
- Prior amputation
- Exercise tolerance limited by factors other than leg pain (e.g. angina, arthritis, severe lung disease, etc).
- Recent (\<3 months) lower-extremity revascularization or orthopedic surgery
- Use of walking aid other than a cane
- Active cancer
- Chronic kidney disease (eGFR \<30 by MDRD or Mayo or Cockcroft-Gault formula)
- Unable to fit into water-circulating trousers
- A Mini-Mental Status Examination score \<23
- Impaired thermal sensation in the leg
- Age lower than 60 yrs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Purdue Universitylead
- Aquilo Sportscollaborator
Study Sites (1)
Purdue University
West Lafayette, Indiana, 47907, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Bruno Tesini Roseguini
- Organization
- Purdue University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 13, 2022
First Posted
April 19, 2022
Study Start
May 30, 2023
Primary Completion
February 7, 2024
Study Completion
February 7, 2024
Last Updated
August 15, 2025
Results First Posted
August 15, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share